###begin article-title 0
Alternative polyadenylation of cyclooxygenase-2
###end article-title 0
###begin p 1
###xml 606 642 606 642 <email xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">journals.permissions@oupjournals.org</email>
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oupjournals.org
###end p 1
###begin p 2
###xml 55 60 55 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX-2</italic>
###xml 119 124 119 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX-1</italic>
###xml 163 168 163 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX-2</italic>
###xml 317 322 317 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX-2</italic>
###xml 535 540 535 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX-2</italic>
###xml 767 774 767 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1188 1195 1188 1195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 25 30 <span type="species:ncbi:9606">human</span>
###xml 492 497 <span type="species:ncbi:9606">human</span>
###xml 529 534 <span type="species:ncbi:9606">human</span>
A biologically important human gene, cyclooxygenase-2 (COX-2), has been proposed to be regulated at many levels. While COX-1 is constitutively expressed in cells, COX-2 is inducible and is upregulated in response to many signals. Since increased transcriptional activity accounts for only part of the upregulation of COX-2, we chose to explore other RNA processing mechanisms in the regulation of this gene. We performed a comprehensive bioinformatics survey, the first of its kind known for human COX-2, which revealed that the human COX-2 gene has alternative polyadenylation (proximal and distal sites) and suggested that use of the alternative polyadenylation signals has tissue specificity. We experimentally established this in HepG2 and HT29 cells. We used an in vivo polyadenylation assay to examine the relative strength of the COX-2 proximal and distal polyadenylation signals, and have shown that the proximal polyadenylation signal is much weaker than the distal one. The efficiency of utilization of many suboptimal mammalian polyadenylation signals is affected by sequence elements located upstream of the AAUAAA, known as upstream efficiency elements (USEs). Here, we used in vivo polyadenylation assays in multiple cell lines to demonstrate that the COX-2 proximal polyadenylation signal contains USEs, mutation of the USEs substantially decreased usage of the proximal signal, and that USE spacing relative to the polyadenylation signal was significant. In addition, mutation of the COX-2 proximal polyadenylation signal to a more optimal sequence enhanced polyadenylation efficiency 3.5-fold. Our data suggest for the first time that alternative polyadenylation of COX-2 is an important post-transcriptional regulatory event.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 110 111 110 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 294 295 294 295 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 574 575 574 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2">2</xref>
###xml 576 577 576 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
Cyclooxygenases (COX) are the key and rate-limiting enzymes in the production of prostaglandins [reviewed in (1) and references therein]. The first steps in prostanoid synthesis are the release of arachidonic acid from membrane phosopholipids by phospholipases and conversion to prostaglandin H2 by COX. Prostaglandins play a role in many biological processes, including but not limited to inflammation, bone formation, wound healing and pain perception. Inflammatory cells as well as other types of cells, including fibroblasts and epithelial cells produce prostaglandins (2,3).
###end p 4
###begin p 5
###xml 45 50 45 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX-1</italic>
###xml 55 60 55 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX-2</italic>
###xml 62 63 62 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">4</xref>
###xml 64 66 64 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">10</xref>
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">11</xref>
###xml 600 601 588 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 602 603 590 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 604 606 592 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 607 609 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
Two separate COX genes have been identified, COX-1 and COX-2 (4-10). A spliced variant of COX-1 (COX-3) has also been identified (11). The proteins that these genes encode are approximately60% identical at the amino acid level. In contrast, the 3'-untranslated regions (3'-UTRs) of COX-1 and COX-2 are highly divergent. The most striking difference between these genes is in their regulation of expression; COX-1 is constitutively expressed while COX-2 is strongly induced in response to activation by hormones, pro-inflammatory cytokines, growth factors, oncogenes, carcinogens and tumor promoters (1-3,12-15).
###end p 5
###begin p 6
###xml 252 253 252 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 254 256 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 257 259 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 481 486 481 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vioxx</italic>
###xml 503 511 503 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Celebrex</italic>
###xml 851 853 851 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 854 856 854 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">33</xref>
###xml 1241 1243 1241 1243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
The physiological or pathological outcomes of COX-2 activity depend upon its level of expression. COX-2 overexpression is associated with a number of conditions, including cancer, rheumatoid arthritis, seizures and inflammatory disorders [reviewed in (1,16-22)]. In addition, COX-2 upregulation contributes to pain; indeed, inhibition of COX-2 enzymatic activities is responsible for the anti-inflammatory properties of aspirin, indomethacin, ibuprofen and related NSAIDs, such as Vioxx (Rofecoxib) and Celebrex (Celecoxib). Molecular events leading to overexpression of COX-2 have not been definitively characterized. Some studies have clearly demonstrated increased levels of COX-2 mRNA in colorectal adenomas, colon cancer cell lines, adenocarcinomas, gastric cancer, breast cancer, certain ovarian and prostate cancers, and non-small lung cancer (22-33). Enhanced COX-2 mRNA transcription may play a role but enhanced COX-2 protein expression most probably requires post-transcriptional gene regulation events, such as are mediated through mRNA processing and mRNA turnover. Indeed, the kinetics of transcriptional activation alone cannot account for the sustained induction of COX-2 mRNA by interleukin 1 in vascular endothelial cells (14).
###end p 6
###begin p 7
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34">34</xref>
###xml 176 178 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37">37</xref>
###xml 234 236 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b38">38</xref>
###xml 237 239 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b41">41</xref>
###xml 317 319 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b42">42</xref>
###xml 827 829 791 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b43">43</xref>
###xml 972 974 936 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b38">38</xref>
###xml 975 977 939 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b41">41</xref>
###xml 1215 1217 1167 1169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b38">38</xref>
###xml 1218 1220 1170 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b41">41</xref>
###xml 1221 1223 1173 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b44">44</xref>
###xml 1224 1226 1176 1178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b52">52</xref>
###xml 1473 1475 1425 1427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b53">53</xref>
###xml 1476 1478 1428 1430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b66">66</xref>
###xml 1614 1616 1566 1568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b65">65</xref>
###xml 738 743 <span type="species:ncbi:9606">human</span>
###xml 796 801 <span type="species:ncbi:10090">mouse</span>
The 3' end of nearly every fully processed eukaryotic mRNA has a poly(A) tail, which has been suggested to influence mRNA stability, translation and transport (reviewed in (34-37)]. Polyadenylation is a two-step process [reviewed in (38-41) and references therein], first involving specific endonucleolytic cleavage (42) at a site determined by binding of polyadenylation factors. The second step involves polymerization of the adenosine (A) tail to an average length of approximately200 residues. Most mammalian polyadenylation signals contain the consensus sequence AAUAAA or a close variant between 10 and 35 nt upstream of the actual cleavage and polyadenylation site. AAUAAA is associated with a frequency of approximately53% of all human polyadenylation signals and approximately59% of all mouse polyadenylation signals (43). This hexamer sequence serves as a binding site for the basal polyadenylation factor cleavage and polyadenylation specificity factor (CPSF) (38-41). Sequences approximately14-35 nt downstream of the polyadenylation signal are also known to be involved in directing polyadenylation by serving as a binding site for the basal polyadenylation factor cleavage stimulation factor (CstF) [(38-41,44-52) and references therein]. Elements upstream of the AAUAAA sequences, known as upstream efficiency elements (USEs), have also been characterized that can enhance polyadenylation efficiency, and have been identified in viral and cellular systems [(53-66) and references therein]. Spacing between the AAUAAA and the USE significantly influences USE efficiency in enhancing polyadenylation (65). Although USEs are polyadenylation efficiency elements, they may also provide additional functions in proper processing.
###end p 7
###begin p 8
###xml 167 169 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b40">40</xref>
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b67">67</xref>
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b69">69</xref>
###xml 285 288 285 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 294 299 294 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
As has been appreciated in recent years, 3' end formation is interconnected to mRNA processing events, as well as to mRNA transcription and transcription termination (40,67-69). This interconnection and execution of a functional mRNA likely results from recognition and utilization of cis- and trans-acting signals.
###end p 8
###begin p 9
###xml 199 201 199 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b70">70</xref>
The 3'-UTR of an mRNA can have a major influence on developmental and tissue-specific regulation of gene expression. In fact, the 3'-UTR has recently been called 'a molecular hotspot for pathology' (70). Regulation of gene expression through the 3'-UTR can include alternative polyadenylation, translational control and differential mRNA stability. Preliminary evidence suggests that regulated polyadenylation and mRNA stability may play a pivotal role in COX-2 expression.
###end p 9
###begin p 10
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX-2</italic>
###xml 79 81 79 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b71">71</xref>
###xml 451 459 415 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 834 836 798 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b64">64</xref>
###xml 837 839 801 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b66">66</xref>
###xml 964 966 928 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b72">72</xref>
###xml 967 969 931 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b73">73</xref>
###xml 1068 1070 1032 1034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b74">74</xref>
###xml 1071 1073 1035 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b76">76</xref>
###xml 1168 1170 1132 1134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b77">77</xref>
###xml 1171 1173 1135 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b79">79</xref>
###xml 1309 1311 1273 1275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b80">80</xref>
###xml 1312 1314 1276 1278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b81">81</xref>
The COX-2 gene is made up of 10 exons; the 3'-UTR is contained within exon 10 (71). The COX-2 3'-UTR is larger than average, encompassing approximately2.5 kb, and has many interesting features. It has several polyadenylation signals, only two of which are commonly used, resulting in mRNAs of approximately2.8 kb using the proximal (with regard to the stop codon) polyadenylation signal or approximately4.6 kb using the distal polyadenylation signal (Figure 1). The proximal polyadenylation signal has a non-consensus CPSF binding site (AUUAAA) yet it is used. It is likely that regulation occurs here, resulting in two mRNAs with different RNA metabolism. Curiously, the mRNA that uses the proximal polyadenylation signal contains putative USEs which are similar in sequence and location to those we and others described previously (64-66). The 3'-UTR also has 22 repeats of an AU-rich motif resembling those known to be involved in regulation of mRNA stability (72,73). Recent studies have found that HuR, or a close variant, binds to these AU-rich elements (AREs) (74-76). Other studies have shown additional RNA binding proteins also may bind to the COX-2 3'-UTR (77-79). Additionally, it has been suggested, but not proven, that tissue specificity might play a role in COX-2 polyadenylation site choice (80,81). The significance of the different tissue distributions of these isoforms has not yet been addressed, and most probably will provide significant revelations with regard to COX-2 expression control.
###end p 10
###begin p 11
###xml 186 189 186 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 195 200 195 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 400 405 <span type="species:ncbi:9606">human</span>
Alternative polyadenylation of the COX-2 3'-UTR results in two mRNAs differing only in their 3' ends. Therefore, the choice of a particular polyadenylation site likely involves specific cis- and trans-acting factors, resulting in RNAs with different metabolism, and ultimately will influence the cytoplasmic fate of the mRNA. This study examines the regulation of alternative 3' end formation in the human COX-2 pre-mRNA. We demonstrate that alternative polyadenylation does occur in the COX-2 mRNA and that the two major, utilized polyadenylation signals (proximal and distal) are different in strength and composition. We also show that alternative polyadenylation of the COX-2 mRNA occurs in a tissue-specific fashion in cells that endogenously overexpress COX-2. The proximal polyadenylation signal contains auxiliary USEs that are important for its efficient usage. These experiments suggest that alternative polyadenylation of COX-2 mRNA is an important level of gene expression regulation, because polyadenylation signal choice will include or exclude additional regulatory elements that may influence the metabolic fate of the mRNA.
###end p 11
###begin title 12
MATERIALS AND METHODS
###end title 12
###begin title 13
Plasmids
###end title 13
###begin p 14
###xml 627 629 621 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b64">64</xref>
###xml 82 87 <span type="species:ncbi:9606">human</span>
###xml 380 385 <span type="species:ncbi:9606">Human</span>
###xml 677 680 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 710 716 <span type="species:ncbi:9913">bovine</span>
###xml 804 810 <span type="species:ncbi:9986">rabbit</span>
Primers for PCR to amplify the proximal and distal polyadenylation signals of the human COX-2 3'-UTR were prepared by the Molecular Resource Facility of UMDNJ-NJMS, and had the sequences as listed in Supplementary Table 2. The COX-2 proximal and distal primers contained BamHI (forward) and PstI (reverse) restriction sites to allow insertion into appropriately digested vectors. Human genomic DNA was used as a template to amplify by PCR the appropriate COX-2 proximal and distal polyadenylation signals and flanking sequences for insertion into pGem4 and pCbetaS vectors. The pCbetaS vector (a gift from David Fritz, UMDNJ) (64) has a multiple cloning site downstream of the CMV promoter and upstream of the bovine growth hormone (BGH) polyadenylation signal. This vector also includes intron 1 of the rabbit beta-globin gene accompanied by the splice donor and acceptor sites. Thus, pCbetaS-proximal and pCbetaS-distal were created.
###end p 14
###begin p 15
The USE mutants, the hexamer mutant and the non-specific mutant were made by PCR-based site-directed mutagenesis using the Stratagene QuikChange kit as per the manufacturer's protocols using the pCbetaS-proximal vector as the template. The USE and non-specific mutant were designed to create BglII restriction sites for ease in screening. The COX-2 proximal 5' deletion (Delta) mutant was made by PCR using primers described in Supplementary Table 2. This construct is lacking 115 bases upstream of the COX-2 proximal polyadenylation signal.
###end p 15
###begin p 16
###xml 36 38 36 38 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GA</underline>
###xml 39 40 39 40 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</underline>
###xml 124 126 124 126 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GA</underline>
###xml 213 215 213 215 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GA</underline>
The USE mutant 1 has the sequence AAGATCAAA instead of the wild-type sequence AATTTGAA; the USE mutant 2 has the sequence AAGATCTAA instead of the wild-type sequence AATTTCTAA; the USE mutant 3 has the sequence GAGATCTTA instead of the wild-type GATTTCTTA. The USE mutants 1,3 and 2,3 had both USEs mutated as described above.
###end p 16
###begin p 17
The pCbetaS-proximal-distal-BGH construct was made in the following manner. The COX-2 distal polyadenylation signal was removed from pCbetaS-distal by BamHI and PstI, then the ends were blunted and inserted into pCbetaS-proximal which had been digested with EcoRV. Therefore, pCbetaS-proximal-distal-BGH has three polyadenylation signals in tandem. The pCbetaS-proximal-distal construct was made by digesting pCbetaS-proximal-distal-BGH with XhoI and KpnI to remove the BGH polyadenylation signal. Therefore, pCbetaS-proximal-distal has both COX-2 polyadenylation signals in tandem.
###end p 17
###begin p 18
###xml 37 53 37 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 287 289 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b66">66</xref>
###xml 37 53 <span type="species:ncbi:562">Escherichia coli</span>
All constructs were transformed into Escherichia coli XL1-Blue cells. Positive clones were sequenced and assayed for expression of the appropriately sized insert. Constructs were verified by sequencing (Molecular Resource Facility, UMDNJ-NJMS). SVL RNA was used as described previously (66).
###end p 18
###begin title 19
Rapid site-directed mutagenesis using two PCR-generated DNA fragments
###end title 19
###begin p 20
The USE double (USE mut 1,2) and triple (USE mut 1,2,3) mutations were generated by standard PCR using KOD polymerase and using the upstream (5') wild-type COX-2 proximal primer containing a BamHI restriction site and a downstream primer (3'; USE 1,2 R) containing the respective site-directed mutagenic base pair changes. Then the upstream mutagenic primer (5'; USE 1,2 F) was used in standard PCR using KOD polymerase and the wild-type COX-2 proximal downstream primer (3') containing a PstI restriction site. The USE 1,2 mut was prepared using COX-2 proximal wild-type DNA template in the PCR, while the USE 1,2,3 mut was prepared using USE 3 mut DNA template. The products of the above two sets of PCR steps were re-amplified using the 5' and 3' wild-type COX-2 proximal primers and the resulting 268 bp fragment was cloned into the BamHI/PstI sites of the pCbetaS vector.
###end p 20
###begin title 21
Mammalian cell culture
###end title 21
###begin p 22
###xml 104 110 <span type="species:ncbi:9913">bovine</span>
###xml 272 278 <span type="species:ncbi:9913">bovine</span>
HeLa, MDA-MD231 and HepG2 cells were maintained in DMEM (Life Technologies) supplemented with 10% fetal bovine serum (Sigma) and 1% penicillin-streptomycin (Life Technologies). HT29 cells were maintained in RPMI-1640 Medium (Life Technologies) supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin.
###end p 22
###begin title 23
Transfection
###end title 23
###begin p 24
###xml 32 33 32 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 749 750 734 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
HeLa or MDA-MB-231 cells (7 x 105 cells/well) were seeded in 60 mm plates approximately12 h before transfection. When cells reached 80% confluency, they were transfected using LT-1 reagent (Mirus). Plasmid DNA (2.8 mug) was diluted in 180 mul of serum-free medium to which 6 mul of LT-1 was added and the mixture was incubated at room temperature for 20 min. Following the addition of 1 ml complete medium to the transfection mixture, the medium on the cells was removed and replaced with the entire transfection cocktail. After 24 h, cells were washed once with 1x phosphate-buffered saline (PBS). Cells were scraped and collected into 1 ml PBS and transferred into microcentrifuge tubes. Cells were then centrifuged at 7000 r.p.m. for 5 min (4500 g in an Eppendorf microcentrifuge). The PBS was aspirated and total RNA was extracted immediately from the cell pellet as described below.
###end p 24
###begin title 25
Total RNA isolation and RNase protection assay
###end title 25
###begin p 26
###xml 40 47 40 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 426 433 425 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 701 703 700 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b64">64</xref>
To determine polyadenylation signal use in vivo, total RNA from transfected cells was assayed by RNase protection. Total RNA was extracted from the cell pellet using either the TRIZOL method (Invitrogen) or the RNeasy Mini Kit (Qiagen) according to the manufacturer's spin protocol for isolation of total RNA from animal cells. For RNase protection assay reactions, 5 mug of total RNA was used per reaction. Probe RNA for the in vivo polyadenylation assay was prepared as described below. The reporter and/or endogenous RNA levels were determined by RNase protection using the RPAIII kit (Ambion Inc., Austin, TX). The RNA was then analyzed on 5% polyacrylamide-8 M urea gels as described previously (64). The ratio of the reporter assay and endogenous band detection was quantified using a Typhoon PhosphorImager and ImageQuant software.
###end p 26
###begin title 27
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
In vitro transcription of RNA substrates
###end title 27
###begin p 28
###xml 20 28 20 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 46 53 46 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 230 232 225 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
RNA transcripts for in vitro polyadenylation, in vivo polyadenylation assays and RNase protection assays were synthesized by use of SP6 or T7 RNA polymerase according to the supplier (Promega) in the presence of 50 muCi of [alpha-32P]UTP (Amersham Pharmacia Biosciences or Perkin Elmer Biosciences). RNAs were purified from 5% polyacrylamide-8 M urea-TBE gels by overnight crush elution in high salt buffer (0.4 M NaCl, 50 mM Tris, pH 8.0 and 0.1% SDS). Prior to use in reactions, eluted RNAs were ethanol precipitated and resuspended in water.
###end p 28
###begin p 29
###xml 273 280 267 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 358 360 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b66">66</xref>
Linearization of all pCbetaS and pGEM4 DNA constructs at the BamHI site and transcription using T7 RNA polymerase as mentioned above generates antisense RNAs. Transcription of CbetaS COX-2 'proximal' yielded a 610 base RNA, of COX-2 'distal' an 854 base RNA for use in the in vivo polyadenylation assay. SVL was linearized with DraI as described previously (66).
###end p 29
###begin title 30
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
In vitro polyadenylation assays
###end title 30
###begin p 31
###xml 51 53 51 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b64">64</xref>
###xml 190 198 190 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 391 393 391 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b64">64</xref>
###xml 409 417 409 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 609 610 609 610 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 621 623 621 623 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 967 969 948 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b64">64</xref>
###xml 254 258 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
HeLa nuclear extracts were prepared as described [(64) and references therein] using HeLa cells purchased from the National Cell Culture Center (Minneapolis, MN) or grown in our laboratory. In vitro polyadenylation assays using HeLa nuclear extract, the SV40 late polyadenylation signal pre-mRNA and COX-2 USE RNA or non-specific oligoribonucleotides were performed as described previously (64). Briefly, the in vitro polyadenylation reactions contain a final concentration of 58% (v/v) HeLa nuclear extract, 16 mM phosphocreatine (Sigma), 0.8 mM ATP (Amersham Biosciences), 2.6% polyvinyl alcohol, and 1 x 105 c.p.m. of 32P-labeled SVL substrate RNA (approximately50 fmol) in a total volume of 12.5 mul. These reactions are incubated at 30degreesC for 1 h. The COX-2 USE 3 RNA oligoribonucleotide was synthesized by Dharmacon Research, Inc. (Lafayette, CO) and had the sequence UUGUUUGAUUUCUUAAAGU. The non-specific RNA oligoribonucleotide was described previously (64).
###end p 31
###begin title 32
Immunoblot analysis
###end title 32
###begin p 33
###xml 49 50 49 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 519 524 <span type="species:ncbi:10090">Mouse</span>
###xml 530 535 <span type="species:ncbi:9606">human</span>
###xml 578 583 <span type="species:ncbi:9606">human</span>
###xml 651 655 <span type="species:ncbi:9925">Goat</span>
###xml 666 677 <span type="species:ncbi:3704">horseradish</span>
Cell lysates were prepared by incubating 1.5 x 106 cells on ice for 30 min in a solution containing 1% NP-40, 150 mM NaCl and 50 mM Tris-HCl (pH 8.0), plus phenylmethylsulfonyl fluoride (50 mug/ml), leupeptin, aprotinin and pepstatin A (each at 1 mug/ml). Protein from cleared lysate (75 mug) was separated by 10% SDS-PAGE, then blotted onto nitrocellulose membrane and blocked in 5% non-fat dry milk. Primary antibody incubations were performed at a dilution of 1:100 in blocking solution for 3 h at room temperature. Mouse anti-human COX-2 monoclonal antibody and recombinant human COX-2 protein were purchased from Cayman Chemical (Ann Arbor, MI). Goat-antimouse horseradish peroxidase-conjugated secondary antibody (ICN) was used at a dilution of 1:5000 for 1 h at room temperature. Visualization of bound antibodies was accomplished through chemiluminescence using an ECL kit (Amersham Pharmacia Biosciences) and autoradiography.
###end p 33
###begin title 34
Bioinformatics
###end title 34
###begin p 35
###xml 66 71 66 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX-2</italic>
###xml 394 396 394 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b43">43</xref>
###xml 60 65 <span type="species:ncbi:9606">human</span>
###xml 298 303 <span type="species:ncbi:9606">human</span>
Expressed sequence tag (EST) sequences corresponding to the human COX-2 gene and their tissue information were obtained from dbEST (March 2004 version; National Center for Biotechnology Information, NCBI), according to the UniGene database (March 2004 version; NCBI). Sequences were aligned to the human genome and polyadenylation sites were determined by using a method described previously [(43) and references therein]. ESTs with poly(A) tail sequence were used to infer polyadenylation sites.
###end p 35
###begin title 36
Statistical analyses
###end title 36
###begin p 37
###xml 107 108 105 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 115 116 113 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Results are expressed as +/-SD of the mean, and analyses were performed by two-sample one-tailed Student's t-test. P-values <0.05 were considered significant.
###end p 37
###begin title 38
RESULTS
###end title 38
###begin title 39
###xml 80 85 80 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX-2</italic>
###xml 74 79 <span type="species:ncbi:9606">human</span>
EST surveys suggest existence of multiple polyadenylation signals for the human COX-2 gene with tissue specificity
###end title 39
###begin p 40
###xml 593 600 593 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 1246 1248 1234 1236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b80">80</xref>
###xml 1249 1251 1237 1239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b81">81</xref>
###xml 1483 1485 1471 1473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b80">80</xref>
###xml 1486 1488 1474 1476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b81">81</xref>
###xml 1494 1502 1482 1490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 1513 1520 1501 1508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 1578 1585 1566 1573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 1697 1704 1685 1692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 70 75 <span type="species:ncbi:9606">human</span>
###xml 260 265 <span type="species:ncbi:9606">human</span>
Because alternative polyadenylation is potentially a key regulator of human COX-2 expression, we systematically investigated the mechanism controlling alternative 3' end formation. Using a bioinformatics approach, we have surveyed the current EST database for human COX-2 mRNAs that would represent utilization of either the proximal or the distal COX-2 polyadenylation signal. Using ESTs with poly(A) tail sequence (see Materials and Methods; B. Tian and C. S. Lutz, unpublished data), we identified three COX-2 polyadenylation signals, named proximal 1, proximal 2 and distal, respectively (Table 1, top). The closed diamonds represent ESTs containing poly(A) tail sequence. The open circles denote ESTs that do not have poly(A) tail sequence. Since these open circles are located after proximal 2, they indirectly support the use of the distal polyadenylation signal, assuming there is no other poly(A) signal between proximal 2 and distal. The distance between proximal 1 and proximal 2 is approximately400 nt, and between proximal 2 and distal is a little less than 2000 nt. Since proximal 1 lacks a definable CstF binding site and previous northern blot data only support transcript sizes resulting from proximal 2 and distal signal usage (80,81), we focused on proximal 2, which we will refer to simply as 'proximal' throughout the rest of our study. The distance between proximal and distal from this EST survey is in good agreement with those reported in previous studies [(80,81) and Figure 1]. Also in Table 1 are cDNA library IDs for the ESTs found (first column in Table 1) and tissue and organ information if known on the biological source of the cDNA libraries (last two columns in Table 1). Use of the COX-2 proximal and distal polyadenylation signals are noted by the numbers of ESTs that appeared from each library.
###end p 40
###begin p 41
###xml 253 260 253 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 555 557 555 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b80">80</xref>
###xml 558 560 558 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b81">81</xref>
###xml 150 155 <span type="species:ncbi:9606">human</span>
To our knowledge, this is the first data for COX-2 examined in this manner. Moreover, our data are comprehensive; all available ESTs corresponding to human COX-2 were used. We would like to highlight that (i) both COX-2 polyadenylation signals are used in vivo; (ii) there are different tissue patterns/distributions and (iii) this is a much larger-scale analysis than has previously been reported. Importantly, these tissue-specific distribution patterns and the polyadenylation signals utilized closely match smaller scale, reported tissue specificity (80,81), with use of the proximal form notably predominating liver, while the distal form notably predominates in colon. Our data underscore the biological relevance of our study and highlight the need for understanding the mechanisms of regulation that are involved.
###end p 41
###begin title 42
Endogenous COX-2 mRNAs are polyadenylated at different sites in cell lines representing different tissues
###end title 42
###begin p 43
###xml 274 276 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b75">75</xref>
###xml 412 421 412 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2A</xref>
###xml 691 700 691 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2A</xref>
###xml 174 179 <span type="species:ncbi:9606">human</span>
To further evaluate the biological usage of both polyadenylation signals with regard to the tissue specificity noted by our bioinformatics analysis, we chose two established human cancer cell lines, HT29 (colon) and HepG2 (liver). Like many colon cancer-derived cell lines (75), HT29 cells constitutively express COX-2 since endogenous COX-2 protein can be readily detected by western blotting in HT29 extracts (Figure 2A, lane 2). The constitutive expression of COX-2 in hepatocellular carcinoma cells such as HepG2 has been debated in the literature. In our hands, COX-2 protein was detected in HepG2 extract indicating that COX-2 is expressing in this hepatocellular carcinoma cell line (Figure 2A, lane 3). The levels of endogenous COX-2 protein appear to be lower in HepG2 cells than in HT29 cells. As a loading control, we probed the same western blot with an antibody specific for glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and found GAPDH to be equivalent in each lane (data not shown).
###end p 43
###begin p 44
###xml 256 258 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b81">81</xref>
###xml 479 488 479 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2B</xref>
###xml 499 507 499 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 823 832 823 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2B</xref>
###xml 1072 1081 1072 1081 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2C</xref>
###xml 1274 1289 1274 1289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2B and C</xref>
It has been reported that the distal COX-2 polyadenylation signal is used in primary colon samples and that the proximal polyadenylation signal is used in liver samples as assayed by northern blots, but this conclusion was based purely on transcript size (81). We therefore decided to perform our assay based on a more precise method of analyzing polyadenylation signal usage. This assay allows us to specifically identify use of the proximal and distal polyadenylation signals (Figure 2B; see also Figure 1). Total RNA was extracted from HT29 and HepG2 cells and this RNA was used in standard RNase protection assays using specific COX-2 proximal and distal probes. pGEM4-distal and pGEM4-proximal antisense probes protected the specific bases corresponding to the proximal and distal polyadenylation signals. The data in Figure 2B show that HT29 cells primarily use the COX-2 distal polyadenylation signal, giving a protected fragment of 235 bp. HepG2 cells utilize both the COX-2 proximal and distal signals, giving protected fragments of 168 and 235 bp, respectively (Figure 2C). The proximal probe is also able to bind to and protect a 268 bp fragment in the distal mRNA, which corresponds to the entire, uncleaved and unused proximal polyadenylation signal (lane 1 in Figure 2B and C). The larger size reflects the fact that sequences downstream of the proximal cleavage site are contained in the distal mRNA. Our data reveal that there is regulated, differential, tissue-specific polyadenylation of COX-2.
###end p 44
###begin title 45
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
In vivo polyadenylation of COX-2 using reporter assays
###end title 45
###begin p 46
###xml 66 73 66 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 95 102 95 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b64">64</xref>
###xml 675 684 672 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3A</xref>
###xml 1069 1078 1060 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3A</xref>
###xml 1552 1561 1543 1552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3B</xref>
###xml 1574 1583 1565 1574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3C</xref>
###xml 533 538 <span type="species:ncbi:9606">human</span>
After confirming that both COX-2 polyadenylation signals are used in vivo, we next applied our in vivo polyadenylation assays (64) to address directly the mechanism controlling use of the COX-2 proximal and distal polyadenylation signals. We first addressed how the suboptimal AUUAAA proximal COX-2 polyadenylation signal behaved in our system. The apparent weakness of this polyadenylation signal was postulated based upon its divergence from the consensus AAUAAA CPSF binding site. We cloned a 268 bp fragment by PCR including the human COX-2 proximal polyadenylation signal and flanking sequences into our two polyadenylation signal reporter vector pCbetaS, diagrammed in Figure 3A. In this series of experiments, the proximal signal was inserted into the signal 1 site while the BGH signal occupied the signal 2 site. This pCbetaS-COX-2-proximal construct was then transformed into HeLa or MDA-MB-231 (breast cancer) cells. Total RNA was isolated after 24 h, RNase protection assays were performed using the antisense probe to the pCbetaS-COX-2-proximal construct (Figure 3A), and the results were quantified using a PhosphorImager and ImageQuant software. RNase protection assays will produce a protected fragment of 168 bases if the COX-2 proximal polyadenylation signal is used; utilization of the BGH signal will produce a protected fragment of 410 bases. We found that polyadenylation at the COX-2 proximal signal compared with that at the BGH signal occurred in a ratio of 1:3, indicating that the proximal COX-2 signal is indeed suboptimal (Figure 3B, lane 4 and Figure 3C).
###end p 46
###begin p 47
###xml 805 814 778 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3B</xref>
###xml 827 836 800 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3D</xref>
###xml 1052 1054 1025 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b64">64</xref>
We next compared polyadenylation using the COX-2 distal polyadenylation signal to BGH by the same type of assay. We cloned a 454 bp fragment by PCR containing the COX-2 distal polyadenylation signal into the pCbetaS vector, with the COX-2 distal signal occupying the polyadenylation signal 1 site in the reporter vector. Use of the COX-2 distal polyadenylation signal in the RNase protection assay will protect a fragment of 235 bases. Because the distal polyadenylation signal has a consensus AAUAAA, we predicted that this signal would be stronger than the proximal polyadenylation signal of COX-2. Indeed, the COX-2 distal polyadenylation signal was stronger than the COX-2 proximal signal, and was used approximately45% of the time compared with polyadenylation at the BGH signal of approximately55% (Figure 3B, lane 5 and Figure 3D). In this set of experiments, the band corresponding to BGH migrated slightly faster than expected. This result was reproducible in this assay, and has been observed previously using the same assay and same vector (64). These assays were performed in HeLa or MDA-MB-231 cells where there is no detectable endogenous COX-2 protein or mRNA (data not shown). These data demonstrate that although both COX-2 polyadenylation signals are used, the COX-2 proximal signal is indeed weak and the COX-2 distal signal is stronger as compared with the internal control.
###end p 47
###begin p 48
###xml 1104 1113 1095 1104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3B</xref>
###xml 1126 1135 1117 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3E</xref>
Since the COX-2 polyadenylation signals are normally in tandem in the COX-2 3'-UTR, and therefore may be in competition with each other, we measured their relative use in a similar assay as described above. Here, the COX-2 proximal and distal polyadenylation signals were both placed in their respective order in the pCbetaS reporter plasmid while keeping the BGH polyadenylation signal intact (pCbetaS-proximal-distal-BGH). After transfection into HeLa cells, RNase protection assays were performed as described above. In this context, the relative use of COX-2 proximal signal was 14.3%, the relative use of the COX-2 distal signal was 53.5%, and the relative use of the BGH polyadenylation signal was 32.2%, giving a ratio of proximal/distal/BGH of 1:3.8:2.3 (data not shown). When the BGH polyadenylation signal was removed to produce a tandem construct (pCbetaS-proximal-distal), transfected into HeLa or MDA-MB-231 cells, RNA isolated and RNase protection assays performed, the ratio of proximal/distal polyadenylation signal usage was 1:3, not appreciably different from when the BGH was present (Figure 3B, lane 7 and Figure 3E). Note that the creation of the pCbetaS-proximal-distal construct caused the resulting protected fragments to differ in size slightly from the results obtained using either the pCbetaS-proximal or the pCbetaS-distal alone. These data demonstrate that the COX-2 proximal polyadenylation signal does not compete significantly with the distal polyadenylation signal in tandem.
###end p 48
###begin title 49
Effect of mutation of core and auxiliary polyadenylation elements in the suboptimal COX-2 proximal polyadenylation signal
###end title 49
###begin p 50
###xml 146 153 146 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 155 164 155 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3B</xref>
###xml 191 199 191 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 311 313 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b82">82</xref>
###xml 314 316 314 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b83">83</xref>
###xml 343 351 343 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 501 508 501 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 526 527 526 527 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</underline>
###xml 559 560 559 560 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</underline>
###xml 602 611 602 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4A</xref>
###xml 950 951 950 951 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</underline>
###xml 960 961 960 961 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</underline>
###xml 1093 1102 1093 1102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4B</xref>
###xml 1259 1266 1259 1266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Since the COX-2 proximal core polyadenylation signal is AUUAAA, and therefore differs from the consensus AAUAAA, we showed that it was suboptimal in vivo (Figure 3B, lanes 4 and 7). Previous in vitro studies in the Wickens and Shenk laboratories had mutated the consensus AAUAAA to every base at each position (82,83). These studies had shown in vitro that while AUUAAA worked better than any other derivative of AAUAAA, it still did not perform as well as the consensus AAUAAA. To further prove this in vivo, we mutated the AUUAAA to the consensus sequence AAUAAA using site-directed mutagenesis (see Figure 4A for diagram). We then measured polyadenylation signal use (relative to BGH polyadenylation signal use) by RNase protection assays as described above. Here, we have calculated fold-induction at the proximal polyadenylation signal; so utilization at the wild-type proximal signal was set at a value of 1. We found that this single change, AUUAAA to AAUAAA mutation, enhanced polyadenylation by 3.5-fold over the level of polyadenylation at the COX-2 proximal polyadenylation signal (Figure 4B), thus acting as a positive mutant. Similar results were found using MDA-MB-231 cells (data not shown). These results confirmed directly for the first time in vivo that the difference between an 'optimal' AAUAAA and a 'suboptimal' AUUAAA core polyadenylation signal is operationally real.
###end p 50
###begin p 51
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b64">64</xref>
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b66">66</xref>
###xml 275 278 275 278 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#8211;5</sub>
###xml 429 438 429 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4A</xref>
###xml 670 677 670 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 910 919 910 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4A</xref>
###xml 1121 1130 1121 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4C</xref>
###xml 1315 1322 1315 1322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1385 1394 1385 1394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4C</xref>
###xml 1574 1583 1574 1583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4C</xref>
###xml 1709 1718 1709 1718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4C</xref>
###xml 1867 1876 1863 1872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4C</xref>
Polyadenylation efficiency can be enhanced by the presence of auxiliary elements located upstream of the CPSF binding site, known as USEs (64-66). Sequences upstream of the COX-2 proximal polyadenylation signal that we identified bear striking similarity to the consensus UAU2-5GUNA USE sequence previously studied in our laboratory. The COX-2 USEs are located 58, 49 and 6 bases upstream of the proximal polyadenylation signal (Figure 4A). We predicted that these putative USEs would affect polyadenylation efficiency of the suboptimal COX-2 proximal polyadenylation signal. In order to experimentally address this prediction, we mutated the USEs in the context of our in vivo polyadenylation construct. Mutants were prepared by PCR-based site-directed mutagenesis in each of the three putative USEs, as well as a non-specific mutant in a non-USE region upstream of the COX-2 proximal polyadenylation signal (Figure 4A). These constructs were then transfected into HeLa (or MDA-MB-231 cells; data not shown), total RNA was isolated and RNase protection assays were performed as described above. The results are shown in Figure 4C. Mutation of each USE was increasingly more deleterious as the USE mutation approached the suboptimal core polyadenylation hexamer element AUUAAA, with USE 3 mutation alone decreasing in vivo polyadenylation to approximately half of the wild-type level (Figure 4C). Mutation of the USEs in duplicate (USE 1,2 mut; USE 2,3 mut; USE 1,3 mut) resulted in approximately the same level of reduced polyadenylation efficiency as the USE 3 mut alone (Figure 4C). However, the triple USE mutation (USE 1,2,3 mut) resulted in a significant decrease in polyadenylation signal utilization (Figure 4C). Deletion of the entire USE-containing region in the 5'Delta mutant almost abolished polyadenylation at the COX-2 proximal polyadenylation signal (Figure 4C). Taken together, these data suggest that the USEs may have additive or synergistic effects. These data also suggest that the USEs are important polyadenylation efficiency elements in the COX-2 proximal polyadenylation signal, and perhaps ensure that the proximal signal is utilized.
###end p 51
###begin title 52
###xml 52 57 52 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
USE competition for polyadenylation suggests that a trans-acting factor could be influencing polyadenylation at signals containing USEs
###end title 52
###begin p 53
###xml 95 103 95 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 186 194 186 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 378 380 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b66">66</xref>
###xml 408 416 408 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 501 503 501 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b64">64</xref>
###xml 612 620 612 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 685 687 685 687 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 713 721 713 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 814 822 814 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 964 979 964 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5A and B</xref>
###xml 981 990 981 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5A</xref>
###xml 1098 1106 1098 1106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1281 1283 1281 1283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b64">64</xref>
###xml 1286 1295 1286 1295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5B</xref>
###xml 1340 1349 1340 1349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5B</xref>
###xml 1534 1542 1534 1542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1685 1694 1685 1694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5B</xref>
###xml 1788 1790 1788 1790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b64">64</xref>
###xml 1791 1793 1791 1793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b66">66</xref>
###xml 1835 1843 1835 1843 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1861 1870 1861 1870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5B</xref>
###xml 1886 1894 1886 1894 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 2061 2070 2061 2070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5C</xref>
###xml 2180 2189 2180 2189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5C</xref>
###xml 235 239 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 361 365 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 420 425 <span type="species:ncbi:9606">human</span>
###xml 864 868 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 2404 2408 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
To further define a functional role of the USEs as auxiliary efficiency elements, we performed in vitro polyadenylation assays using specific competitors. Previously, we have shown that in vitro polyadenylation reactions containing an SV40 late polyadenylation signal substrate RNA (SVL) could be inhibited specifically by oligoribonucleotides representing the SV40 USE motifs (66), and that polyadenylation in vitro of human COL1A2 substrate RNA can be inhibited by a COL1A2 USE oligoribonucleotide (64). We now prepared an oligoribonucleotide that represents COX-2 USE 3, and added this oligoribonucleotide to in vitro polyadenylation reactions containing HeLa nuclear extract and a 32P-labeled SVL prepared by in vitro transcription using SP6 polymerase. This substrate RNA was chosen because it works well for in vitro polyadenylation, and because the USEs in SV40 are similar to those found in the proximal COX-2 polyadenylation signal. The data are shown in Figure 5A and B. Figure 5A demonstrates graphically that the COX-2 USE oligoribonucleotide specifically inhibited SVL polyadenylation in vitro, whereas a non-specific oligoribonucleotide had no significant effect on SVL polyadenylation. An additional non-specific oligonucleotide also had no effect (data not shown) (64). Figure 5B shows representative experiments. Lane 1 in Figure 5B, both upper and lower panels, represents a reaction performed in the absence of competitor oligoribonucleotides and demonstrates that the SVL RNA was efficiently polyadenylated in the in vitro system. Interestingly, 50 pmol of the COX-2 USE 3 oligoribonucleotide specifically inhibited polyadenylation to <10% of the control reaction (Figure 5B, upper panel). This amount is similar to other USE oligoribonucleotide inhibition reactions (64,66). The non-specific oligo did not inhibit in vitro polyadenylation (Figure 5B, lower panel). In vitro polyadenylation of a non-USE containing polyadenylation signal, AAV, was also not inhibited by the addition of the COX-2 USE 3 at similar concentrations as expected (Figure 5C). Polyadenylation of AAV was also not affected by addition of the non-specific oligonucleotides as expected (Figure 5C). Taken together, these data demonstrate that the COX-2 USE 3 oligoribonucleotide specifically binds and sequesters a putative common factor(s) important for polyadenylation, and suggest that the similarity to the SV40 USE motifs is functionally significant.
###end p 53
###begin title 54
DISCUSSION
###end title 54
###begin p 55
###xml 672 674 672 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b84">84</xref>
###xml 675 677 675 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b85">85</xref>
Polyadenylation is a useful and underexplored mechanism of regulating gene expression, and this regulation is partially implied by the complex nature of this process. Alternative polyadenylation can generate mature transcripts that only differ in their 3' ends. Efficiency of processing is another level at which regulation can occur, since most pre-mRNAs in the cell are not efficiently processed, and therefore, even small changes in the overall processing efficiency of a particular pre-mRNA may have a great effect on ultimate protein levels. Experimental evidence has demonstrated that poly(A) signal strength directly influences the amount of mature, exported mRNA (84,85).
###end p 55
###begin p 56
###xml 1097 1104 1097 1104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 119 124 <span type="species:ncbi:9606">human</span>
###xml 207 212 <span type="species:ncbi:9606">human</span>
###xml 214 224 <span type="species:ncbi:9598">chimpanzee</span>
###xml 226 231 <span type="species:ncbi:10090">mouse</span>
###xml 236 239 <span type="species:ncbi:10116">rat</span>
###xml 520 525 <span type="species:ncbi:10090">mouse</span>
Our objective in this study was to accurately define and characterize alternative polyadenylation as it applied to the human COX-2 3'-UTR. Interestingly, the size and scheme of the 3'-UTR is conserved among human, chimpanzee, mouse and rat COX-2 genes, along with the two polyadenylation signals, suggesting that the importance of alternative polyadenylation plays a key regulatory function (B. Tian, H. Zhang, and C. S. Lutz, unpublished data). Indeed, the sequences for USEs 1 and 2 are exact matches in the 3'-UTR of mouse COX-2 homolog (B. Tian, H. Zhang, and C. S. Lutz, unpublished data). Choice of a particular polyadenylation signal may result in mRNAs with different stability or different translation efficiency, which has direct consequences for how much protein product is ultimately produced. Therefore, polyadenylation signal choice can be a key step in mRNA maturation. Our work examined the relative strength and composition of the COX-2 proximal and distal polyadenylation signals. We have shown that the COX-2 proximal and COX-2 distal polyadenylation signals are utilized in an in vivo polyadenylation assay. We further demonstrated that the use of these COX-2 polyadenylation signals is regulated in a tissue-specific manner. We propose that while basal polyadenylation of these signals does occur experimentally in cell types that do not normally express COX-2 mRNA (HeLa and MDA-MB-231), the cell-type specific utilization of COX-2 proximal and distal polyadenylation signals may require additional as yet unidentified factors.
###end p 56
###begin p 57
###xml 206 214 206 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6</xref>
###xml 370 372 370 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b81">81</xref>
Additionally, we have demonstrated that a suboptimal CPSF binding site (AUUAAA) is truly weaker than the canonical CPSF binding site, AAUAAA. Taken together, the data suggest a working hypothesis, shown in Figure 6, for polyadenylation signal choice, as well as for possible correlations between polyadenylation signal choice and resulting mRNA stability as postulated (81).
###end p 57
###begin p 58
###xml 11 19 11 19 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6</xref>
###xml 541 543 541 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b72">72</xref>
###xml 544 546 544 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b73">73</xref>
###xml 599 607 599 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 891 893 891 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b86">86</xref>
###xml 999 1001 999 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b87">87</xref>
###xml 1002 1004 1002 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b88">88</xref>
###xml 1213 1215 1213 1215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b81">81</xref>
Our model (Figure 6) suggests that use of the COX-2 proximal polyadenylation signal results in a shorter mRNA, while use of the COX-2 distal polyadenylation signal results in a longer mRNA. Use of the proximal polyadenylation signal would exclude a portion of the 3'-UTR, which may contain important regulatory elements, for example, elements that regulate mRNA stability. The best characterized 3'-UTR sequences that cause mRNA instability are the AREs found in many short-lived mRNAs such as cytokines, growth factors and proto-oncogenes (72,73). The 3'-UTR of COX-2 is complex and has many AREs (Figure 1). Currently, data in the literature conflict with regard to which form of COX-2 is more stable. It has been shown that removal of some sequences upstream of the COX-2 proximal polyadenylation signal containing some of the AREs confers increased stability to a heterologous reporter (86), while other data have shown that this same region can transfer instability to a heterologous reporter (87,88). Additionally, the longer COX-2 mRNA has been reported to be the more unstable form as revealed by northern blotting of the COX-2 mRNA while the shorter form is generally thought to be the more stable form (81). While our study has not addressed these questions of stability directly, our study underscores the importance of understanding how alternative polyadenylation of COX-2 is regulated.
###end p 58
###begin p 59
###xml 138 145 138 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 243 252 243 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4C</xref>
###xml 494 499 494 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
We have also demonstrated here that the USEs present in the suboptimal COX-2 proximal polyadenylation signal have a significant effect on in vivo polyadenylation of that signal, since mutation or deletion of the USEs has a substantial effect (Figure 4C). We suggest that the presence of the USEs in the COX-2 proximal polyadenylation signal ensure its usage, possibly by supporting and enhancing assembly of the basal polyadenylation machinery on the polyadenylation signal, or by serving as a trans-acting factor binding site which may recruit or enhance interactions with the basal polyadenylation machinery. These explanations are not mutually exclusive. Additionally, tissue-specific factors may be involved since we have shown tissue-specific utilization occurs at the COX-2 proximal polyadenylation signal. These details remain to be explored.
###end p 59
###begin title 60
SUPPLEMENTARY MATERIAL
###end title 60
###begin p 61
Supplementary Material is available at NAR Online.
###end p 61
###begin title 62
Supplementary Material
###end title 62
###begin title 63
[Supplementary Material]
###end title 63
###begin p 64
We thank the members of the Lutz, O'Connor, Rogers, Bellofatto, Modak and Wilusz laboratories for helpful experimental suggestions and comments on this manuscript. Special thanks to David Fritz for helpful suggestions and Matias Elijovich for technical assistance. This work was funded by American Cancer Society Grant RPG-00-265-01-GMC and NSF award MCB-0426195 to C.S.L. Funding to pay the Open Access publication charges for this article was provided by NSF award MCB-0426195.
###end p 64
###begin p 65
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement</italic>
Conflict of interest statement. None declared.
###end p 65
###begin title 66
REFERENCES
###end title 66
###begin article-title 67
Cyclooxygenase-1 and -2 isoenzymes
###end article-title 67
###begin article-title 68
Benzo[a]pyrene up-regulates cyclooxygenase-2 gene expression in oral epithelial cells
###end article-title 68
###begin article-title 69
###xml 55 58 <span type="species:ncbi:10116">rat</span>
Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor alpha and phorbol ester
###end article-title 69
###begin article-title 70
###xml 26 31 <span type="species:ncbi:9606">human</span>
Isolation of the cDNA for human prostaglandin H synthase
###end article-title 70
###begin article-title 71
###xml 53 58 <span type="species:ncbi:9940">sheep</span>
Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from complementary DNA sequence
###end article-title 71
###begin article-title 72
###xml 60 65 <span type="species:ncbi:9940">sheep</span>
Isolation and characterization of the complementary DNA for sheep seminal vesicle prostaglandin endoperoxidase synthase (cyclooxygenase)
###end article-title 72
###begin article-title 73
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human cyclooxygenase-2 cDNA
###end article-title 73
###begin article-title 74
cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase
###end article-title 74
###begin article-title 75
Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing
###end article-title 75
###begin article-title 76
The structure of mammalian cyclooxygenases
###end article-title 76
###begin article-title 77
COX-3, a cyclooxygenase-1 variant inhibitied by acetaminophen and other analgesic/antipyretic drugs: cloning, structure and expression
###end article-title 77
###begin article-title 78
Platelet-activating factor and retinoic acid synergistically activate the inducible prostaglandin synthase gene
###end article-title 78
###begin article-title 79
###xml 107 112 <span type="species:ncbi:9606">human</span>
Cyclooxygenase gene expression is down-regulated by heparin-binding (acidic fibroblast) growth factor-1 in human endothelial cells
###end article-title 79
###begin article-title 80
Induction of cyclooxygenase-2 by interleukin-1 alpha. Evidence for post-transcriptional regulation
###end article-title 80
###begin article-title 81
###xml 86 92 <span type="species:ncbi:10090">murine</span>
Interleukin-1 beta induces prostaglandin G/H synthase-2 (cyclooxygenase-2) in primary murine astrocyte cultures
###end article-title 81
###begin article-title 82
COX-2 as a multifunctional neuronal modulator
###end article-title 82
###begin article-title 83
Prostaglandins and the regulation of tumor growth
###end article-title 83
###begin article-title 84
Cyclooxygenase gene expression in inflammation and angiogenesis
###end article-title 84
###begin article-title 85
The role of cyclooxygenases in inflammation, cancer and development
###end article-title 85
###begin article-title 86
Is cyclooxygenase-2 the alpha and omega in cancer?
###end article-title 86
###begin article-title 87
Cyclooxygenase-2 and carcinogenesis
###end article-title 87
###begin article-title 88
Dysregulated post-transcriptional control of COX-2 gene expression in cancer
###end article-title 88
###begin article-title 89
###xml 55 60 <span type="species:ncbi:9606">human</span>
Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer
###end article-title 89
###begin article-title 90
###xml 52 57 <span type="species:ncbi:9606">human</span>
Upregulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
###end article-title 90
###begin article-title 91
Non-small cell lung cancer cyclooxygenase activity and proliferation are inhibited by non-steroidal anti-inflammatory drugs
###end article-title 91
###begin article-title 92
###xml 52 57 <span type="species:ncbi:9606">human</span>
Prostaglandin synthase 2 is abnormally expressed in human colon cancer: evidence for a transcriptional effect
###end article-title 92
###begin article-title 93
###xml 80 85 <span type="species:ncbi:9606">human</span>
Gene expression of cyclooxygenase-2, group,II and cytosolic phospholipase A2 in human colorectal cancer
###end article-title 93
###begin article-title 94
###xml 41 46 <span type="species:ncbi:9606">human</span>
Expression of cyclooxygenase-1 and -2 in human colorectal cancer
###end article-title 94
###begin article-title 95
Host cyclooxygenase-2 modulates carcinoma growth
###end article-title 95
###begin article-title 96
###xml 58 63 <span type="species:ncbi:9606">human</span>
Cyclooxygenase-2 is up-regulated by interleukin-1 beta in human colorectal cancer cells via multiple signaling pathways
###end article-title 96
###begin article-title 97
Cyclooxygenase-2 expression and angiogenesis in colorectal cancer
###end article-title 97
###begin article-title 98
###xml 122 130 <span type="species:ncbi:9606">patients</span>
Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma
###end article-title 98
###begin article-title 99
Expression of cyclooxygenase-2 in cervical, endometrial, and ovarian malignancies
###end article-title 99
###begin article-title 100
The influence of 5' and 3' end structures on pre-mRNA metabolism
###end article-title 100
###begin article-title 101
Interrelationships of the pathways of mRNA decay and translation in eukaryotic cells
###end article-title 101
###begin article-title 102
Starting at the beginning, middle and end: translation initiation in eukaryotes
###end article-title 102
###begin article-title 103
Life and death in the cytoplasm: messages from the 3' end
###end article-title 103
###begin article-title 104
Mechanism and regulation of mRNA polyadenylation
###end article-title 104
###begin article-title 105
A history of polyA sequences: from formation to factors to function
###end article-title 105
###begin article-title 106
New perspectives on connecting messenger RNA 3' end formation to transcription
###end article-title 106
###begin article-title 107
The mechanism of 3' cleavage and polyadenylation of eukaryotic pre-mRNA
###end article-title 107
###begin article-title 108
Evidence that polyadenylation factor CPSF-73 is the mRNA 3' processing endonuclease
###end article-title 108
###begin article-title 109
###xml 50 55 <span type="species:ncbi:9606">human</span>
###xml 60 65 <span type="species:ncbi:10090">mouse</span>
A large scale analysis of mRNA polyadenylation of human and mouse genes
###end article-title 109
###begin article-title 110
Cleavage site determinants in the mammalian polyadenylation signal
###end article-title 110
###begin article-title 111
Auxiliary downstream elements are required for efficient polyadenylation of mammalian pre-mRNAs
###end article-title 111
###begin article-title 112
###xml 48 54 <span type="species:ncbi:9986">rabbit</span>
A sequence downstream of AAUAAA is required for rabbit beta-globin mRNA 3' end formation
###end article-title 112
###begin article-title 113
###xml 85 91 <span type="species:ncbi:9986">rabbit</span>
Position-dependent sequence elements downstream of AAUAAA are required for efficient rabbit beta-globin mRNA formation
###end article-title 113
###begin article-title 114
Requirement of a downstream sequence for generation of a poly(A) addition site
###end article-title 114
###begin article-title 115
###xml 85 100 <span type="species:ncbi:10633">simian virus 40</span>
Identification of a sequence element on the 3' side of AAUAAA which is necessary for simian virus 40 late mRNA 3' end processing
###end article-title 115
###begin article-title 116
###xml 61 76 <span type="species:ncbi:10633">simian virus 40</span>
A sequence downstream of AAUAAA is required for formation of simian virus 40 late mRNA in 3' termini in frog oocytes
###end article-title 116
###begin article-title 117
A uridylate tract mediates efficient heterogeneous nuclear ribonucleoprotein C protein-RNA crosslinking and functionally substitutes for the downstream element of the polyadenylation signal
###end article-title 117
###begin article-title 118
###xml 84 92 84 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Sequences downstream of AAUAAA signals affect pre-mRNA cleavage and polyadenylation in vitro both directly and indirectly
###end article-title 118
###begin article-title 119
###xml 37 42 <span type="species:ncbi:9606">human</span>
Efficient polyadenylation within the human immunodeficiency type 1 long terminal repeat inhibits polyadenylation of its own pre-mRNA
###end article-title 119
###begin article-title 120
###xml 33 48 <span type="species:ncbi:10633">simian virus 40</span>
Efficiency of utilization of the simian virus 40 late polyadenylation site: effects of upstream sequences
###end article-title 120
###begin article-title 121
###xml 99 134 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Involvement of long terminal repeat U3 sequences overlapping the transcriptional control region in human immunodeficiency virus type 1 mRNA 3' end formation
###end article-title 121
###begin article-title 122
The relationship between the prothrombin upstream sequence element and the G20210A polymorphism: the influence of a competitive environment for mRNA 3' end formation
###end article-title 122
###begin article-title 123
###xml 138 146 138 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 43 71 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Elements upstream of the AAUAAA within the human immunodeficiency virus polyadenylation signal are required for efficient polyadenylation in vitro
###end article-title 123
###begin article-title 124
###xml 43 51 43 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 14 19 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Activation of HIV-1 pre-mRNA 3' processing in vitro requires both an upstream element and TAR
###end article-title 124
###begin article-title 125
###xml 24 29 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
CPSF recognition of and HIV-1 mRNA 3' processing enhancer: multiple sequence contacts involved in poly(A) site definition
###end article-title 125
###begin article-title 126
###xml 20 44 <span type="species:ncbi:10641">cauliflower mosaic virus</span>
A dissection of the cauliflower mosaic virus polyadenylation signal
###end article-title 126
###begin article-title 127
Regulation of polyadenylation in hepatitis B viruses: stimulation by the upstream activating signal PS1 is orientation-dependent, distance-dependent, and additive
###end article-title 127
###begin article-title 128
Upstream sequence elements enhance poly(A) site efficiency of the C2 complement gene and are phylogenetically conserved
###end article-title 128
###begin article-title 129
The upstream sequence element of the C2 complement poly(A) signal activates mRNA 3' end formation by two distinct mechanisms
###end article-title 129
###begin article-title 130
Upstream elements present in the 3' UTR of collagen gene influence the processing efficiency of overlapping polyadenylation signals
###end article-title 130
###begin article-title 131
###xml 106 114 106 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 53 68 <span type="species:ncbi:10633">simian virus 40</span>
Definition of the upstream efficiency element of the simian virus 40 late polyadenylation signal by using in vitro analyses
###end article-title 131
###begin article-title 132
###xml 88 92 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Direct interaction of the U1snRNP-A protein with the upstream efficiency element of the SV40 late polyadenylation signal
###end article-title 132
###begin article-title 133
An extensive network of coupling among gene expression machines
###end article-title 133
###begin article-title 134
Integrating mRNA processing with transcription
###end article-title 134
###begin article-title 135
Formation of mRNA 3' ends in eukaryotes: mechanism, regulation and interrelationships with other steps in mRNA synthesis
###end article-title 135
###begin article-title 136
The 3' untranslated region of messenger RNA: a molecular hotspot for pathology?
###end article-title 136
###begin article-title 137
###xml 17 22 <span type="species:ncbi:9606">human</span>
Structure of the human cyclo-oxygenase-2 gene
###end article-title 137
###begin article-title 138
A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation
###end article-title 138
###begin article-title 139
AU-rich elements: characterization and importance in mRNA degradation
###end article-title 139
###begin article-title 140
Identification of a novel AU-rich element-binding protein which is related to AUF-1
###end article-title 140
###begin article-title 141
Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells
###end article-title 141
###begin article-title 142
HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements within the 3' untranslated regions of cytokine and angiogenic factor mRNAs
###end article-title 142
###begin article-title 143
The RNA-binding protein HuR regulates the expression of cyclooxygenase-2
###end article-title 143
###begin article-title 144
Tristetraprolin binds to the 3'-untranslated region of cyclooxygenase-2 mRNA. A polyadenylation variant in a cancer cell line lacks the binding site
###end article-title 144
###begin article-title 145
Regulation of cyclooxygenase-2 expression by the translational silencer TIA-1
###end article-title 145
###begin article-title 146
###xml 24 27 <span type="species:ncbi:10116">rat</span>
Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression
###end article-title 146
###begin article-title 147
Cyclooxygenase 2 RNA message abundance, stability and hypervariability in sporadic Alzheimer neocortex
###end article-title 147
###begin article-title 148
###xml 128 136 128 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Point mutations in AAUAAA and the poly(A) addition site: effects on the accuracy and efficiency of cleavage and polyadenylation in vitro
###end article-title 148
###begin article-title 149
###xml 66 70 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Functional analysis of point mutations in the AAUAAA motif of the SV40 late polyadenylation signal
###end article-title 149
###begin article-title 150
Patterns of polyadenylation site selection in gene constructs containing multiple polyadenylation signals
###end article-title 150
###begin article-title 151
3' RNA processing efficiency plays a primary role in generating termination-competent RNA polymerase II elongation complexes
###end article-title 151
###begin article-title 152
###xml 30 36 <span type="species:ncbi:10090">murine</span>
The 3' untranslated region of murine cyclooxygenase-2 contains multiple regulatory elements that alter message stability and translational efficiency
###end article-title 152
###begin article-title 153
Post-transcriptional control of cyclooxygenase gene expression
###end article-title 153
###begin article-title 154
###xml 84 89 <span type="species:ncbi:9606">human</span>
Dissociation of basal turnover and cytokine-induced transcript stabilization of the human cyclooxygenase-2 mRNA by mutagenesis of the 3'-untranslated region
###end article-title 154
###begin title 155
Figures and Tables
###end title 155
###begin p 156
###xml 87 92 87 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX-2</italic>
###xml 32 37 <span type="species:ncbi:9606">human</span>
###xml 81 86 <span type="species:ncbi:9606">human</span>
Schematic representation of the human COX-2 3'-UTR. Diagram of the 3'-UTR of the human COX-2 gene highlighting the major polyadenylation signals; resulting mRNAs are also depicted. Putative auxiliary USEs are represented by hatched boxes; checkered boxes represent CstF binding sites; AREs are represented by dotted ovals. Bottom: sequence of a portion of the COX-2 proximal polyadenylation signal. Putative USEs are italicized, underlined and noted above the sequence.
###end p 156
###begin p 157
###xml 79 80 79 80 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 241 242 239 240 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 247 248 245 246 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
Tissue-specific alternative polyadenylation of COX-2 in HT29 and HepG2 cells. (A) Western blot of 75 mug total protein cell extract from HT29 and HepG2 cells using an anti-COX-2 monoclonal antibody. Lane 1, 1 mug recombinant COX-2 protein. (B and C) RNase protection assays using endogenous RNA from HT29 (B) and HepG2 (C) cells along with COX-2 proximal and/or distal probes. The data shown in (B), lane 2, illustrate that HT29 cells primarily use the COX-2 distal polyadenylation signal. (C) HepG2 cells utilizing the COX-2 proximal signal in lane 1 and the distal signal in lane 2. The band corresponding to utilization of the COX-2 proximal polyadenylation signal is marked with an asterisk; the band corresponding to utilization of the COX-2 distal polyadenylation signal is marked with an arrow.
###end p 157
###begin p 158
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 124 125 124 125 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 198 205 195 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 559 560 550 551 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 603 610 594 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 736 738 723 725 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 950 951 928 929 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1207 1208 1182 1183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</italic>
###xml 1273 1274 1248 1249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">y</italic>
###xml 1422 1423 1397 1398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1444 1447 1419 1422 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;13</sup>
###xml 1450 1451 1425 1426 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1705 1706 1677 1678 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</italic>
###xml 1789 1790 1761 1762 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">y</italic>
###xml 1938 1939 1910 1911 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1961 1962 1933 1934 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 2281 2282 2250 2251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">y</italic>
###xml 2430 2431 2399 2400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
In vivo polyadenylation assays demonstrate the relative strength of the COX-2 proximal and distal polyadenylation signals. (A) Schematic representation of the pCbetaS reporter construct used in the in vivo polyadenylation assay. The relative position of each polyadenylation signal is diagramed. The BGH polyadenylation signal is always located at poly(A) site 2. The proximal and distal constructs have those respective sequences cloned into poly(A) site 1. Only the pCbetaS-proximal-distal-BGH and pCbetaS-proximal-distal constructs vary from this scheme. (B) Representative RNase protection data for in vivo polyadenylation assays using these constructs. Lane 1, size markers from pBR322 cut with MspI and 5' end labeled with [gamma-32P]ATP as indicated; lane 2, undigested probe; lane 3, pCbetaS empty vector; lanes 4 and 5, COX-2 constructs in pCbetaS as indicated above the lane; lane 6, undigested probe; and lane 7, pCbetaS-proximal-distal. (C) pCbetaS-proximal was transfected into HeLa (closed bars) or MDA-MB-231 cells (gray bars), RNA was isolated after 24 h, and RNase protection assays were performed. Quantification of three independent experiments is shown here. Constructs are shown on the x-axis; percent use of either the proximal or BGH is shown on the y-axis. The percent utilization was calculated based on the ratio of each signal being utilized within each experiment. Error bars represent SD. All P-values are <1.9 x 10-13. (D) pCbetaS-distal was transfected into HeLa (closed bars) or MDA-MB-231 cells (gray bars), RNA was isolated after 24 h, and RNase protection assays were performed. Quantification of three independent experiments is shown here. Constructs are shown on the x-axis; percent use either the distal or BGH polyadenylation signal is shown on the y-axis. The percent utilization was calculated based on the ratio of each signal being utilized within each experiment. Error bars represent SD. All P-values are <0.0008. (E) pCbetaS-proximal-distal was transfected into HeLa (closed bars) or MDA-MB-231 cells (gray bars), RNA was isolated after 24 h, and RNase protection assays were performed. Quantification of three independent experiments is shown here. Percent use of either the proximal or distal polyadenylation signal is shown on the y-axis. The percent utilization was calculated based on the ratio of each signal being utilized within each experiment. Error bars represent SD. All P-values were <0.005.
###end p 158
###begin p 159
###xml 104 105 104 105 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 313 314 313 314 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 634 635 631 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</italic>
###xml 721 722 718 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">y</italic>
###xml 758 759 755 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 782 783 779 780 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1094 1095 1087 1088 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</italic>
###xml 1181 1182 1174 1175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">y</italic>
###xml 1218 1219 1211 1212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
A positive mutant and mutation of the USEs influence use of the COX-2 proximal polyadenylation signal. (A) Diagram showing COX-2 proximal polyadenylation signal and mutations prepared. Closed rectangles represent mutations; hatched rectangles represent USEs; and checkered boxes represent the CstF binding site. (B) Mutants were prepared of the COX-2 proximal polyadenylation signal by site-directed mutagenesis and were cloned into pCbetaS, transfected into HeLa cells, RNA was isolated after 24 h, and RNase protection assays were performed. Quantification of four independent experiments is shown here. Constructs are shown on the x-axis; fold-induction of polyadenylation at the COX-2 proximal signal is shown on the y-axis. Error bars represent SD. All P-values were <0.0029. (C) USE single mutants, double mutants and the triple mutant, as well as the 5'Delta mutant were prepared as described, transfected into HeLa cells, RNA was isolated after 24 h, and RNase protection assays were performed. Quantification of three independent experiments is shown here. Constructs are shown on the x-axis; fold-induction of polyadenylation at the COX-2 proximal signal is shown on the y-axis. Error bars represent SD. All P-values were <0.0017.
###end p 159
###begin p 160
###xml 127 128 127 128 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 158 166 158 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 304 305 304 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</italic>
###xml 362 363 362 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">y</italic>
###xml 507 508 507 508 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 525 533 525 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 997 998 997 998 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1028 1036 1028 1036 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 566 570 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Competition studies suggest USE binding factors influence the processing efficiency of COX-2 proximal polyadenylation signal. (A) Graphical representation of in vitro competitions using SVL and either COX-2 USE oligoribonucleotide (squares) or non-specific oligoribonucleotide (diamonds). Numbers on the x-axis represent pmol of competitor added, numbers on the y-axis represent percent polyadenylation. This quantification represents the average of three independent experiments. Error bars represent SD. (B) Representative in vitro polyadenylation reactions using SV40 late polyadenylation signal RNA as the substrate RNA and increasing amounts of either COX-2 USE oligoribonucleotide as competitor (upper panel) and non-specific oligoribonucleotide as competitor (lower panel). Amounts of competitor used in both sets of reactions are as follows: lane 1s, no competitor; lane 2s, 1 pmol competitor; lane 3s, 10 pmol; lane 4s, 20 pmol; lane 5s, 37 pmol; lane 6s, 50 pmol; and lane 7s, 75 pmol. (C) Graphical representation of in vitro competitions using AAV substrate RNA and either COX-2 USE oligoribonucleotide (squares) or non-specific oligoribonucleotide (diamonds).
###end p 160
###begin p 161
Working model of alternative polyadenylation in COX-2.
###end p 161
###begin p 162
Expressed sequence tag survey result of COX-2 polyadenylation signals
###end p 162
###begin p 163
Top: genomic sequence of COX-2 3'-UTR containing three polyadenylation signals is depicted schematically. The position of proximal 1 is arbitrarily set as 0. Closed diamonds denote the locations of poly(A) signals supported by ESTs with poly(A) tail sequence. Open circles are the locations of the 3' end of ESTs without poly(A) tail sequence. Bottom: LIB_ID corresponds to cDNA library ID in the dbEST database. P1, proximal 1; P2, proximal 2; D, distal; and D1, distal supported by ESTs without poly(A) tail sequence (explained in the text).
###end p 163

